Patents by Inventor Kohei Iwamoto

Kohei Iwamoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230372262
    Abstract: Provided is a composition for the treatment of vascular disease, for the prevention of vascular disease, for the treatment of hypertension or for the prevention of hypertension, comprising caryophyllene.
    Type: Application
    Filed: November 1, 2021
    Publication date: November 23, 2023
    Inventors: Nobuhiro ZAIMA, Chihiro KISHI, Yuki TAKEMOTO, Shinichi MATSUMURA, Yuri YOSHIOKA, Kohei IWAMOTO, Shohei MAKINO, Kazuya YAMADA, Takanori KOBAYASHI
  • Publication number: 20230200435
    Abstract: Provided are a novel agent or composition and others. The agent or composition comprises caryophyllene and is used for at least one selected from the following (purposes) (1) to (3) : (1) promoting relaxation, prolonging a resting-state time, and/or prolonging a motionless time, (2) promoting sleep, and (3) preventing blood pressure elevation. The present invention also relates to a method for inhaling ?-caryophyllene simultaneously with smoking a tobacco product, characterized in that the tobacco product contains a ?-caryophyllene-containing seamless capsule in a tobacco filter, wherein the seamless capsule contains an essential oil containing ?-caryophyllene as an active ingredient. The applicants found that pulmonary inhalation of ?-caryophyllene by the above method allows ?-caryophyllene to be efficiently distributed throughout the body, leading to achievements of relaxing and sleep-inducing effects, etc.
    Type: Application
    Filed: March 10, 2021
    Publication date: June 29, 2023
    Applicants: KINKI UNIVERSITY, INABATA KORYO CO., LTD., SUNSHO PHARMACEUTICAL CO., LTD.
    Inventors: Nobuhiro ZAIMA, Yuri YOSHIOKA, Shinichi MATSUMURA, Kohei IWAMOTO, Kazuya YAMADA, Takanori KOBAYASHI
  • Publication number: 20210393604
    Abstract: The present invention relates to a medicament for treating or preventing a disease involving Nav 1.7, specifically such neuropathic pain, nociceptive pain, inflammatory pain, small-fiber neuropathy, erythromelalgia, paroxysmal extreme pain disorder, dysuria, and multiple sclerosis, comprising a compound of formula (I) wherein R1a, R1b, R1c, and R1d are hydrogen, halogen, cyano, C1-4 alkyl, C1-4 alkoxy, etc., provided that at least one of R1a, R1b, R1c and R1d is the above C6-10 aryl, C6-10 aryloxy, etc., R2 and R3 are hydrogen, C1-6 alkyl, C3-10 cycloalkyl, etc., R4 is hydrogen, C1-6 alkyl, C3-4cycloalkyl, etc., m is 0, 1, 2, or 3, L is CR7R8, R7 and R8 are hydrogen, hydroxy group, C1-4 alkyl, C1-4 alkoxy, etc., or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 14, 2018
    Publication date: December 23, 2021
    Inventors: Shingo Mizushima, Masaki Watanabe, Kohei Iwamoto, Kuniko Urashima
  • Patent number: 11066372
    Abstract: The present invention relates to a medicament for treating or preventing a disease involving Na channel, for example, neuropathic pain, nociceptive pain, inflammatory pain, small-fiber neuropathy, erythromelalgia, paroxysmal extreme pain disorder, dysuria, or multiple sclerosis, comprising a compound of formula (I) wherein R1a, R1b, R1c, and R1d are hydrogen, halogen, cyano, C1-4 alkyl, C1-4 alkoxy, etc., provided that at least one of R1a, R1b, R1c and R1d is the above C6-10 aryl, C6-10 aryloxy, etc., R2 and R3 are hydrogen, C1-6 alkyl, C3-10 cycloalkyl, etc., R4 is hydrogen, C1-6 alkyl, C3-7 cycloalkyl, etc., m is 0, 1, or 2, L is CR7R8, R7 and R8 are hydrogen, hydroxy group, C1-4 alkyl, C1-4 alkoxy, etc., or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: July 20, 2021
    Assignee: Sumitomo Dainippon Pharma Co., Ltd.
    Inventors: Toshio Kanai, Kohei Iwamoto
  • Patent number: 10956096
    Abstract: Systems, apparatus, and methods are provided to prevent mismatches in processing and settings related to print media. A print manager device includes a media print information storage storing media print information, which is information relating image processing information used to generate print data for a specific print medium with print settings information used to print on the print medium. The image processing information and the print settings information are relationally stored to each printer configured to print based on the print data according to the print settings information. A processor that controls communication. The processor can send the image processing information stored in the media print information storage relationally to a print medium specified by media selection information to an image processing device that generates print data and can send the print settings information stored in the media print information storage to the printer.
    Type: Grant
    Filed: October 21, 2019
    Date of Patent: March 23, 2021
    Assignee: Seiko Epson Corporation
    Inventors: Masahiko Hirasawa, Kohei Iwamoto
  • Publication number: 20200050407
    Abstract: Systems, apparatus, and methods are provided to prevent mismatches in processing and settings related to print media. A print manager device includes a media print information storage storing media print information, which is information relating image processing information used to generate print data for a specific print medium with print settings information used to print on the print medium. The image processing information and the print settings information are relationally stored to each printer configured to print based on the print data according to the print settings information. A processor that controls communication. The processor can send the image processing information stored in the media print information storage relationally to a print medium specified by media selection information to an image processing device that generates print data and can send the print settings information stored in the media print information storage to the printer.
    Type: Application
    Filed: October 21, 2019
    Publication date: February 13, 2020
    Inventors: Masahiko HIRASAWA, Kohei IWAMOTO
  • Publication number: 20200017450
    Abstract: The present invention relates to a medicament for treating or preventing a disease involving Na channel, for example, neuropathic pain, nociceptive pain, inflammatory pain, small-fiber neuropathy, erythromelalgia, paroxysmal extreme pain disorder, dysuria, or multiple sclerosis, comprising a compound of formula (I) wherein R1a, R1b, R1c, and R1d are hydrogen, halogen, cyano, C1-4 alkyl, C1-4 alkoxy, etc., provided that at least one of R1a, R1b, R1c and R1d is the above C6-10 aryl, C6-10 aryloxy, etc., R2 and R3 are hydrogen, C1-6 alkyl, C3-10 cycloalkyl, etc., R4 is hydrogen, C1-6 alkyl, C3-7 cycloalkyl, etc., m is 0, 1, or 2, L is CR7R8, R7 and R8 are hydrogen, hydroxy group, C1-4 alkyl, C1-4 alkoxy, etc., or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 14, 2018
    Publication date: January 16, 2020
    Inventors: Toshio Kanai, Kohei Iwamoto
  • Patent number: 10506123
    Abstract: Provided is technology reducing the capacity required to store actual parameter information by establishing conditions enabling providing actual parameter information to the device that uses the actual parameter information. A control device 5 has label information storage 321 storing label information relationally to combinations of printer 3 models and print media; and actual content storage 322 storing, relationally to the label information, actual parameter information that is used by printers 3 to print to print media. When a combination of printer 3 model and print medium is identified and actual parameter information corresponding to that combination is requested, the control device 5 references the label information storage 321, identifies the label information corresponding to that combination, and acquires actual parameter information from the actual content storage 322 based on the identified label information.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: December 10, 2019
    Assignee: Seiko Epson Corporation
    Inventors: Kohei Iwamoto, Masahiko Hirasawa
  • Patent number: 10462320
    Abstract: There is provided an information processing system that sets a setting value corresponding to a combination of a model of a printing apparatus and a print medium on which printing is performed to a setting item of the printing apparatus and that executes printing, the system including: a setting value table which stores a candidate setting value that can be set to the setting item in correlation with label information corresponding to each candidate setting value, in which, in a case of setting the setting value to the setting item of the printing apparatus, the information processing system determines the setting value corresponding to the setting item based on print medium information including the label information by using the setting value table, and sets the determined setting value to the setting item.
    Type: Grant
    Filed: January 30, 2018
    Date of Patent: October 29, 2019
    Assignee: Seiko Epson Corporation
    Inventors: Kohei Iwamoto, Masahiko Hirasawa
  • Patent number: 10407395
    Abstract: The present invention provides a medicament for treating a disease involving Nav 1.7 such as neuropathic pain, nociceptive pain, inflammatory pain, small-fiber neuropathy, erythromelalgia, paroxysmal extreme pain disorder, dysuria, and multiple sclerosis, which comprises a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein R1a, R1b, R1c and R1d are hydrogen, halogen, cyano, C1-4 alkyl, C1-4 alkoxy, or the like, provided that at least one of R1a, R1b, R1c and R1d is C6-10 aryl, C6-10 aryloxy, or the like, R2 and R3 are hydrogen, C1-6 alkyl, C3-10 cycloalkyl, or the like, R4 is hydrogen, C1-6 alkyl, C3-7 cycloalkyl, or the like, m is 1, 2 or 3, L is CR7R8, and R7 and R8 are hydrogen, hydroxyl, C1-4 alkyl, C1-4 alkoxy, or the like.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: September 10, 2019
    Assignee: Sumitomo Dainippon Pharma Co., Ltd.
    Inventors: Masafumi Komiya, Kohei Iwamoto, Toshio Kanai, Shingo Mizushima, Keiji Adachi, Kuniko Urashima
  • Publication number: 20180285034
    Abstract: Provided is a method enabling easily determining the color characteristics of the print medium, and enabling a printer to print according to the color characteristics of the print medium. An information processing system 1 enables printing based on media properties information for a particular print medium by dividing the ranges of values three parameters in the HSV color space, hue, saturation, and value, can take into multiple intervals; assigning an interval name to each interval; using a specific combination of the interval names for the three parameters as media properties information; using the media properties information to identify a particular piece in a media piece group dividing the HSV color space based on print medium dependency; and printing on the print medium based on the media properties information for the specific print medium.
    Type: Application
    Filed: March 19, 2018
    Publication date: October 4, 2018
    Inventors: Kohei IWAMOTO, Hikonosuke UWAI, Satoshi MORIYAMA
  • Publication number: 20180249021
    Abstract: Provided is technology reducing the capacity required to store actual parameter information by establishing conditions enabling providing actual parameter information to the device that uses the actual parameter information. A control device 5 has label information storage 321 storing label information relationally to combinations of printer 3 models and print media; and actual content storage 322 storing, relationally to the label information, actual parameter information that is used by printers 3 to print to print media. When a combination of printer 3 model and print medium is identified and actual parameter information corresponding to that combination is requested, the control device 5 references the label information storage 321, identifies the label information corresponding to that combination, and acquires actual parameter information from the actual content storage 322 based on the identified label information.
    Type: Application
    Filed: February 27, 2018
    Publication date: August 30, 2018
    Inventors: Kohei IWAMOTO, Masahiko HIRASAWA
  • Publication number: 20180249020
    Abstract: There is provided an information processing system that sets a setting value corresponding to a combination of a model of a printing apparatus and a print medium on which printing is performed to a setting item of the printing apparatus and that executes printing, the system including: a setting value table which stores a candidate setting value that can be set to the setting item in correlation with label information corresponding to each candidate setting value, in which, in a case of setting the setting value to the setting item of the printing apparatus, the information processing system determines the setting value corresponding to the setting item based on print medium information including the label information by using the setting value table, and sets the determined setting value to the setting item.
    Type: Application
    Filed: January 30, 2018
    Publication date: August 30, 2018
    Inventors: Kohei IWAMOTO, Masahiko HIRASAWA
  • Publication number: 20180170881
    Abstract: The present invention provides a medicament for treating a disease involving Nav 1.7 such as neuropathic pain, nociceptive pain, inflammatory pain, small-fiber neuropathy, erythromelalgia, paroxysmal extreme pain disorder, dysuria, and multiple sclerosis, which comprises a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein R1a, R1b, R1c and R1d are hydrogen, halogen, cyano, C1-4 alkyl, C1-4 alkoxy, or the like, provided that at least one of R1a, R1b, R1c and R1d is C6-10 aryl, C6-10 aryloxy, or the like, R2 and R3 are hydrogen, C1-6 alkyl, C3-10 cycloalkyl, or the like, R4 is hydrogen, C1-6 alkyl, C3-7 cycloalkyl, or the like, m is 1, 2 or 3, L is CR7R8, and R7 and R8 are hydrogen, hydroxyl, C1-4 alkyl, C1-4 alkoxy, or the like.
    Type: Application
    Filed: September 9, 2016
    Publication date: June 21, 2018
    Inventors: Masafumi Komiya, Kohei Iwamoto, Toshio Kanai, Shingo Mizushima, Keiji Adachi, Kuniko Urashima
  • Publication number: 20180129455
    Abstract: Systems, apparatus, and methods are provide to prevent mismatches in processing and settings related to print media. A print manager device includes a media print information storage storing media print information, which is information relating image processing information used to generate print data for a specific print medium with print settings information used to print on the print medium. The image processing information and the print settings information are relationally stored to each printer configured to print based on the print data according to the print settings information. A processor that controls communication. The processor can send the image processing information stored in the media print information storage relationally to a print medium specified by media selection information to an image processing device that generates print data and can send the print settings information stored in the media print information storage to the printer.
    Type: Application
    Filed: October 25, 2017
    Publication date: May 10, 2018
    Inventors: Masahiko HIRASAWA, Kohei IWAMOTO
  • Patent number: 9688670
    Abstract: The present invention provides a medicament for treating a disease involving Nav 1.7 such as neuropathic pain, nociceptive pain, inflammatory pain, small-fiber neuropathy, erythromelalgia, paroxysmal extreme pain disorder, dysuria, and multiple sclerosis, which comprises a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein R1a, R1b, R1c and R1d are hydrogen, halogen, cyano, C1-4 alkyl, C1-4 alkoxy, or the like, provided that at least one of R1a, R1b, R1c and R1d is C6-10 aryl, C6-10 aryloxy, or the like, R2 and R3 are hydrogen, C1-6 alkyl, C3-10 cycloalkyl, or the like, R4 is hydrogen, C1-6 alkyl, C3-7 cycloalkyl, or the like, m is 1, 2 or 3, L is CR7R8, and R7 and R8 are hydrogen, hydroxyl, C1-4 alkyl, C1-4 alkoxy, or the like.
    Type: Grant
    Filed: December 30, 2016
    Date of Patent: June 27, 2017
    Assignee: Sumitomo Dainippon Pharma Co., Ltd.
    Inventors: Masafumi Komiya, Kohei Iwamoto, Toshio Kanai, Shingo Mizushima, Keiji Adachi, Kuniko Urashima
  • Publication number: 20170107211
    Abstract: The present invention provides a medicament for treating a disease involving Nav 1.7 such as neuropathic pain, nociceptive pain, inflammatory pain, small-fiber neuropathy, erythromelalgia, paroxysmal extreme pain disorder, dysuria, and multiple sclerosis, which comprises a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein R1a, R1b, R1c and R1d are hydrogen, halogen, cyano, C1-4 alkyl, C1-4 alkoxy, or the like, provided that at least one of R1a, R1b, R1c and R1d is C6-10 aryl, C6-10 aryloxy, or the like, R2 and R3 are hydrogen, C1-6 alkyl, C3-10 cycloalkyl, or the like, R4 is hydrogen, C1-6 alkyl, C3-7 cycloalkyl, or the like, m is 1, 2 or 3, L is CR7R8, and R7 and R8 are hydrogen, hydroxyl, C1-4 alkyl, C1-4 alkoxy, or the like.
    Type: Application
    Filed: December 30, 2016
    Publication date: April 20, 2017
    Inventors: Masafumi Komiya, Kohei Iwamoto, Toshio Kanai, Shingo Mizushima, Keiji Adachi, Kuniko Urashima
  • Publication number: 20160156811
    Abstract: A color adjustment method includes: selecting, as a first color, a color of a color adjustment region in an image region of image data, from a color sample table printed on a medium similar to a medium to be used when an image based on the image data is printed (steps S1, S2); printing a color variable chart in which a plurality of colors are arranged with the first color at a center, on a medium similar to the medium to be used when the image is printed (step S4); selecting, as a second color, a color to be used for color adjustment in the color adjustment region, from the printed color variable chart (steps S5, S6); and converting the color of the color adjustment region in the image data into the second color (step S7).
    Type: Application
    Filed: November 23, 2015
    Publication date: June 2, 2016
    Applicant: SEIKO EPSON CORPORATION
    Inventors: Kohei IWAMOTO, Tatsuro OSHIKAWA, Kazumi YAMADA, Satoru ONO
  • Patent number: 9100623
    Abstract: An image processing device includes an image processing part configured to perform image processing to an original image including a background and an object by adding a first texture component to at least the background.
    Type: Grant
    Filed: May 22, 2012
    Date of Patent: August 4, 2015
    Assignee: Seiko Epson Corporation
    Inventor: Kohei Iwamoto
  • Publication number: 20120300233
    Abstract: An image processing device includes an image processing part configured to perform image processing to an original image including a background and an object by adding a first texture component to at least the background.
    Type: Application
    Filed: May 22, 2012
    Publication date: November 29, 2012
    Applicant: SEIKO EPSON CORPORATION
    Inventor: Kohei IWAMOTO